hematopoietic system
• increased proliferative response of B cells to activation by the B cell reseptor but not by LPS or CD40
|
• enhanced proliferation in response to antiCD3
• increased IL-2 production after antiCD3 stimulation
• there is a generally enhanced ability of T cells to proliferate
• reduced sensitivity of T cells to apoptotic challenge
|
• moderate splenomegaly due to a general increase in spleen cells
|
• leading to splenomegaly
|
• overstimulation of IL-4 production and T helper 2 cells
|
immune system
• increased proliferative response of B cells to activation by the B cell reseptor but not by LPS or CD40
|
• enhanced proliferation in response to antiCD3
• increased IL-2 production after antiCD3 stimulation
• there is a generally enhanced ability of T cells to proliferate
• reduced sensitivity of T cells to apoptotic challenge
|
• moderate splenomegaly due to a general increase in spleen cells
|
• leading to splenomegaly
|
• overstimulation of IL-4 production and T helper 2 cells
|
cellular
• level of apoptosis induced in embryonic fibroblasts by TNF-alpha together with cyclohexamide is less than in wild-type mice
|
• increased proliferative response of B cells to activation by the B cell reseptor but not by LPS or CD40
|
• enhanced proliferation in response to antiCD3
• increased IL-2 production after antiCD3 stimulation
• there is a generally enhanced ability of T cells to proliferate
• reduced sensitivity of T cells to apoptotic challenge
|
growth/size/body
• moderate splenomegaly due to a general increase in spleen cells
|
• leading to splenomegaly
|